You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Will ‘responsible AI’ spawn a new market for tech?
This year’s gathering features HLTH‘s signature opulence and spectacle: as usual, a hair salon for attendees, an indoor puppy park, and a vast exhibit floor crammed with flashy booths, giveaways and high-tech demos. I narrowly dodged the below quadruped as it roamed the showroom; still unclear to me if it had anything to do with health.
Between high-profile panels and offline hallway conversations, chatter seems to be concentrated on a few themes: GLP-1s, the wildly popular weight loss drugs, and their potential to make Americans healthier; AI co-pilots for every role in health care; and guardrails (or lack thereof) for cutting-edge tech in medicine.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
